台股 » 個股 » 杏國 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

杏國

(4192)
  • 股價
    44.00
  • 漲跌
    ▼0.50
  • 漲幅
    -1.12%
  • 成交量
    11
  • 產業
    上櫃 生技醫療類股
  • 120人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
杏國 (4192)籌碼相關-國票-內壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

國票-內壢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/06/210.143.6500.0043.500.1530.19%
2024/06/19043.7000.0043.800530.00%
2021/12/03130.9000.0031.0511,4830.07%
2021/11/10143.9500.0043.9511,4890.07%
2021/10/0400.0014142.50129.50-141,235-1.13%
2021/10/0114143.5000.00143.50141,1891.18%
2021/09/3000.0017131.00132.00-171,148-1.48%
2021/09/2817116.5000.00119.00171,0631.60%
2021/09/2700.004114.75114.50-41,042-0.38%
2021/09/244117.0000.00118.5041,0120.40%
2021/08/2700.00188.2088.50-1608-0.16%
2021/08/17190.0000.0088.0014520.22%
2021/08/1200.00286.1086.10-2397-0.50%
2021/08/1100.00184.0078.30-1365-0.27%
2021/08/10181.5000.0086.9013400.29%
2020/11/2500.00150.4048.70-1376-0.27%
2020/11/23150.7000.0050.5013940.25%
2020/11/2000.00552.7052.50-5401-1.25%
2020/11/19550.8000.0055.1053971.26%
2020/11/0900.00348.1047.85-3429-0.70%
2020/10/1600.001054.6854.00-10623-1.60%
2020/10/13156.00256.0055.90-1661-0.15%
2020/10/12156.40156.2056.3006920.00%
2020/10/08858.6500.0058.2086931.15%
2020/10/06258.8500.0059.6027280.27%
2020/09/2500.00860.0060.30-8746-1.07%
2020/09/2400.00261.9561.50-2756-0.26%
2020/09/23160.9000.0061.1017730.13%
2020/09/21565.46265.0065.0037830.38%
2020/09/18263.6500.0066.2027900.25%
2020/09/17162.7000.0062.2018060.12%
2020/09/1500.00162.7067.10-1825-0.12%
2020/09/14360.00361.3061.0008340.00%
2020/09/11163.1000.0063.0018400.12%
2020/09/09568.3400.0067.8058700.57%
2020/09/08166.6000.0070.4018900.11%
2020/09/07168.8000.0067.1019250.11%
2020/09/0300.001371.7871.40-13949-1.37%
2020/08/241378.8000.0079.50139061.43%
2020/08/06292.2500.0086.2028240.24%
2020/07/3100.00165.7072.20-1738-0.14%
2020/07/29158.40161.2059.8007200.00%
2020/07/28158.40160.0058.4007110.00%
2020/07/23172.80176.4073.5006860.00%
2020/07/2100.00172.9066.50-1667-0.15%
2020/07/20173.8000.0073.8016470.15%
2020/07/161106.5000.0091.0016180.16%
2020/06/2400.00169.0068.50-1425-0.24%
2020/06/2300.00174.0072.10-1407-0.25%
2020/06/16161.6000.0060.5012900.34%
2020/06/11159.8000.0056.7012250.44%
2019/06/1900.00128.5028.70-141-2.43%
2019/06/18130.0000.0028.651392.52%
2019/01/1000.00124.9024.70-146-2.17%
2018/11/2300.00224.5024.50-252-3.79%
2018/10/0900.00226.1526.35-249-4.01%
2018/09/19530.3000.0029.0054511.04%
2018/06/2500.00227.1527.05-283-2.38%
2018/06/2100.00727.3427.45-784-8.27%
2018/05/24527.2500.0027.4051114.49%
2018/05/1500.001028.2128.35-10128-7.78%
2018/05/04128.8500.0029.3511350.74%
2018/04/16129.8000.0029.6011280.78%
2018/04/11130.1500.0030.2011250.80%
2018/03/30231.0500.0030.7521131.76%
2018/03/2900.00433.1032.50-4105-3.80%
2018/03/2700.00130.5030.50-191-1.10%
2018/03/22130.3000.0030.301871.14%
2018/02/27130.2500.0029.701631.56%
2018/02/26130.7000.0030.551631.58%
2018/02/23330.47130.6030.802623.19%
2018/02/12131.4500.0031.201581.71%
杏國將在歐洲腫瘤內科學會亞洲年會 發表胰臟癌臨床結果UDN聯合新聞網-2022/09/25
杏國胰臟癌新藥三期試驗喊卡 待美FDA通知補件Anue鉅亨-2022/05/18
杏國 相關文章